BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12054478)

  • 1. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A.
    Katula KS; Fields A; Apple P; Rotruck T
    Arch Biochem Biophys; 2002 May; 401(2):271-6. PubMed ID: 12054478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
    Noh EJ; Lee JS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
    Nuckolls FJ; Khan AS; Butler R; Katula KS
    Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA.
    Nair AR; Boersma LJ; Schiltz L; Chaudhry MA; Muschel RJ
    Cancer Lett; 2001 May; 166(1):55-64. PubMed ID: 11295287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
    Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
    Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
    Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
    Noh EJ; Lim DS; Jeong G; Lee JS
    Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
    Adachi N; Nomoto M; Kohno K; Koyama H
    Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.